Primary Care Clinics in Kotzebue, AK Accepting Medicare
5 Primary Care Clinics found. Showing 1 - 5
 Maniilaq Association Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 436 5th & Ted Stevens Way, Kotzebue, AK 99752 Phone: 907-442-3321 Fax: 907-442-7250 |
Maniilaq Association Clinic/Center - Primary Care Medicare: Not Enrolled in Medicare Practice Location: 436 & 5th Ted Stevens Way, Kotzebue, AK 99752 Phone: 907-442-2865 Fax: 907-442-7233 |
Maniilaq Health Center Clinic/Center - Community Health Medicare: Not Enrolled in Medicare Practice Location: 436 5th & Ted Stevens Way, Kotzebue, AK 99752 Phone: 907-442-3321 Fax: 907-442-7250 |
Maniilaq Health Center Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 436 5th & Ted Stevens Way, Kotzebue, AK 99752 Phone: 907-442-3321 Fax: 907-442-7250 |
Maniilaq Health Center Clinic/Center - Rural Health Medicare: Not Enrolled in Medicare Practice Location: 436 5th & Ted Stevens Way, Kotzebue, AK 99752 Phone: 907-442-3321 Fax: 907-442-7250 |
News Archive
Scripps researcher receives U-M's Eric J. Topol Professorship in Cardiovascular Medicine
The University of Michigan Medical School today announced the establishment of the Eric J. Topol Professorship in Cardiovascular Medicine. A world-renowned cardiologist, Dr. Topol is currently chief academic officer at Scripps Health and a senior cardiologist practitioner at Scripps Clinic.
Surprising number of doctors prescribe placebos
The revelation that doctors in the U.S. commonly prescribe placebos has surprised many.
BIND Therapeutics presents positive Phase 1 clinical study results for BIND-014 at AACR meeting
BIND Therapeutics, a clinical-stage biopharmaceutical company developing a new class of highly selective targeted and programmable therapeutics called AccurinsTM, announced today that positive Phase 1 clinical data for BIND-014, the company's lead drug candidate, were presented today in an oral presentation at the American Association for Cancer Research 2013 Annual Meeting.
Radiologist creates dramatic teaching tool using power of VR
Physicians, trainees and even laypeople can now stand right beside an expert radiologist as he performs one of the most difficult medical procedures of its kind - in virtual reality.
CDR recommends reimbursement for schizophrenia drug, ABILIFY
Bristol-Myers Squibb Canada is pleased to announce that the Common Drug Review (CDR) has recognized the value of ABILIFY® (aripiprazole) for the treatment of schizophrenia and schizoaffective disorders by recommending it be reimbursed by provincial drug plans for patients who have a contraindication to less-expensive antipsychotic agents or who have failed a trial of less expensive antipsychotic agents due to intolerance or lack of response.
› Verified 2 days ago